相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Fibroblast growth factor 21 is a metabolic regulator that plays a role in the adaptation to ketosis
Eleni M. Domouzoglou et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2011)
ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
Alberico L. Catapano et al.
ATHEROSCLEROSIS (2011)
Circadian Rhythm of Circulating Fibroblast Growth Factor 21 Is Related to Diurnal Changes in Fatty Acids in Humans
Haoyong Yu et al.
CLINICAL CHEMISTRY (2011)
Fibroblast growth factor 21: effects on carbohydrate and lipid metabolism in health and disease
Susan Kralisch et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2011)
High Plasma Level of Fibroblast Growth Factor 21 Is an Independent Predictor of Type 2 Diabetes A 5.4-year population-based prospective study in Chinese subjects
Cheng Chen et al.
DIABETES CARE (2011)
Serum FGF21 levels are increased in newly diagnosed type 2 diabetes with nonalcoholic fatty liver disease and associated with hsCRP levels independently
Xuesong Li et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study
Anu Suomalainen et al.
LANCET NEUROLOGY (2011)
Relation between fibroblast growth factor-21, adiposity, metabolism, and weight reduction
Knut Mai et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Circulating Fibroblast Growth Factor 21 Levels Are Closely Associated with Hepatic Fat Content: A Cross-Sectional Study
Hongmei Yan et al.
PLOS ONE (2011)
Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease
Yusuf Yilmaz et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2010)
Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease
Jody Dushay et al.
GASTROENTEROLOGY (2010)
Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride
Huating Li et al.
JOURNAL OF HEPATOLOGY (2010)
Hypocaloric high-protein diet improves fatty liver and hypertriglyceridemia in sucrose-fed obese rats via two pathways
Takashi Uebanso et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Circulating Fibroblast Growth Factor-21 Is Elevated in Impaired Glucose Tolerance and Type 2 Diabetes and Correlates With Muscle and Hepatic Insulin Resistance
Alberto O. Chavez et al.
DIABETES CARE (2009)
Response to Carbohydrate and Fat Refeeding in the Expression of Genes Involved in Nutrient Partitioning and Metabolism: Striking Effects on Fibroblast Growth Factor-21 Induction
J. Sanchez et al.
ENDOCRINOLOGY (2009)
The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARα activation in man
Cecilia Gaelman et al.
CELL METABOLISM (2008)
Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans
Xinmei Zhang et al.
DIABETES (2008)
Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa
Ivana Dostalova et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Postprandial triglyceride-rich lipoproteins in insulin resistance and Type 2 diabetes
Niina Matikainen et al.
FUTURE LIPIDOLOGY (2008)
Postprandial lipemia associates with liver fat content
Niina Matikainen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Hepatic fibroblast growth factor 21 is regulated by PPARα and is a key mediator of hepatic lipid metabolism in ketotic states
Michael K. Badman et al.
CELL METABOLISM (2007)
Overproduction of large VLDL particles is driven by increased liver fat content in man
M Adiels et al.
DIABETOLOGIA (2006)
Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population
LS Szczepaniak et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
分享论文
